Highmark Commercial Medical Policy in Delaware


 
Printer Friendly Version

Section: Visits
Number: V-23
Version: 003
Topic: Temporomandibular Joint (TMJ) Dysfunction
Effective Date: January 13, 2014
Issued Date: January 13, 2014
Date Last Reviewed: 06/2013

General Policy Guidelines

Indications and Limitations of Coverage

Coverage for treatment of temporomandibular joint (TMJ) dysfunction is determined according to individual or group customer benefits.

There are three basic approaches to the treatment of TMJ syndrome:

  1. Medical-Surgical: Medical visits, arthrocentesis, and injections of the joint may be considered medically necessary when reported with a diagnosis of TMJ dysfunction.

    Physical medicine (including modalities such as heat/cold treatment, manipulation, and electrogalvanic electrical stimulation) may be considered medically necessary when provided as treatment for TMJ syndrome.

    Transcutaneous electrical nerve stimulation (TENS) may be considered medically necessary when provided in the assessment of TMJ dysfunction. (Refer to Medical Policy Bulletin Z-7 for additional guidelines of TENS).

    Vapo-coolant spray (ethyl chloride) is a surface (local) anesthetic and should be denied. A participating, preferred, or network provider can bill the member for the denied service.

    Manipulation for the reduction of a fracture or dislocation of the temporomandibular joint (e.g., 21480-21490), or manipulation of the joint under anesthesia (21073), are considered surgical procedures and should be paid as such. However, these codes are inappropriate for treatment of TMJ dysfunction without dislocation and will be denied as not medically necessary. Codes 21480, 21490 are to be used only for a dislocated condyle beyond the eminentia to the fossa.

    Arthroscopic procedures of the temporomandibular joint are eligible for payment. Diagnostic arthroscopy is to be coded as 29800. Therapeutic arthroscopy is to be coded as 29804.

    NOTE:
    Major surgical intervention is rarely required in the treatment of TMJ dysfunction. Any claim for a major surgical procedure such as a meniscectomy, arthroplasty, or total condylectomy should be referred for medical review.

    Diagnostic x-rays taken in conjunction with the treatment of TMJ dysfunction are eligible for reimbursement. Claims reporting such x-rays should be processed under the appropriate diagnostic radiology code (the 70000 series). Specifically excluded from coverage are the dental radiography codes (D0210-D0350).

    Cephalograms (70350) and pantograms (70355) will be reviewed for medical necessity on an individual consideration basis.

    The following services are ineligible for payment on the basis that they are not of proven value in the diagnosis of this condition:

    Electromyography (EMG) (95867, 95868)
    Iontophoresis (97033)
    Lateral skull x-rays (70250-70260)
    Neuromuscular junction testing (95937)
    Somatosensory testing (95925)
    Nuclear medicine studies (78300, 78305)
    Transcranial x-rays (70250-70260)
    Ultrasound (76536)
  2. Psychiatric/Psychological: TMJ dysfunction is often a psychosomatic condition, usually resulting from tension or stress. Bruxism is a common tension habit which can lead to the TMJ syndrome. Payment should be made for psychiatric/psychological visits if reported as such with a diagnosis of TMJ dysfunction.

  3. Mechanical: Any method to alter occlusion of the teeth is considered a mechanical approach. Frequently, an intraoral appliance (D7880, S8262) will be prescribed. The intraoral appliance is excluded from coverage under the medical-surgical programs. Whether performed by a dentist or physician, this approach to the treatment of TMJ syndrome is not eligible for reimbursement.

    The jaw motion rehabilitation system, Therabite, a manual, hand-held, single patient use device is eligible for reimbursement. Procedure codes E1700-E1702 should be used to report this device.

    See Medical Policy Bulletin E-1 for information on the eligibility of jaw motion rehabilitation systems.

The following may be considered medically necessary for the treatment of TMJ dysfunction:

  • Arthrogram (70332) indicated for presurgical evaluation. Should not be performed in addition to an MRI scan.
  • CT scan (70486-70488) - indicated for hard tissue presurgical evaluation.
  • Injection of anesthetic agent, trigeminal nerve (64400) - allow only once per course of treatment.
  • Muscle testing (95831) - refer to Medical Policy Bulletin V-31 for information.
  • MRI scan (70336) - indicated for soft tissue presurgical evaluation.
  • Physical medicine, in general, should not exceed four weeks in duration.
    NOTE:
    Additional physical medicine services are eligible only with documentation for individual consideration.
  • Range of motion measurements (95851) - refer to Medical Policy Bulletin V-31 for information.
  • The following services are ineligible for payment on the basis that they are not of proven value in the diagnosis of this condition:
Kinesiography (97799)
Ultrasonic doppler auscultation

See Medical Policy Bulletin Y-1 guidelines regarding physical medicine coverage.

Place of Service: Outpatient

Diagnosis and treatment for Temporomandibular Joint (TMJ) Dysfunction is typically an outpatient procedure which is only eligible for coverage as an inpatient procedure in special circumstances including, but not limited to the presence of a co-morbid condition that would require monitoring in a more controlled environment such as the inpatient setting.

Description

The temporomandibular joint connects the mandible (lower jaw) and the temporal bone (located in front of the ears). Dysfunction of this joint can involve hard or soft tissues and may be caused by either organic disease or functional joint abnormalities. Symptoms are varied and include, but are not limited to, clicking sounds in the jaw, headaches, trismus, and pain in the ears, neck, arms, and spine. TMJ dysfunction can also be referred to as any of the following: cranial-cervical syndrome, myofascial pain-dysfunction syndrome, asymmetrical motor neuropathy, cervicalgia, localized myospasm, cephalgia, musculoskeletal dysfunction, neural entrapment, vascular instability, myalgia/myositis.


NOTE:
This policy is designed to address medical guidelines that are appropriate for the majority of individuals with a particular disease, illness, or condition. Each person's unique clinical circumstances may warrant individual consideration, based on review of applicable medical records.

Procedure Codes

210732148021485214902980029804
644007025070260703327033670350
703557048670487704887653678300
783059583195851958679586895925
959379703397799D0210D0220D0230
D0240D0250D0260D0270D0272D0273
D0274D0277D0290D0310D0320D0321
D0322D0330D0340D0350D7880E1700
E1701E1702S8262   

Traditional Guidelines

Refer to General Policy Guidelines

FEP Guidelines

This medical policy may not apply to FEP. Medical policy is not an authorization, certification, explanation of benefits or a contract. Benefits are determined by the Federal Employee Program.

EPO/PPO Guidelines

Refer to General Policy Guidelines

Any reference in this bulletin to non-billable services by a network provider may not be applicable to Major Medical.

HMO/POS Guidelines

Refer to General Policy Guidelines

Publications

Provider Medical Policies Update

08/2013, Place of service designation included on additional medical policies

Facility Bulletin

12/2013, TMJ DYSFUNCTION AND FOOT ORTHOTICS FOR CONDITIONS OTHER THAN DIABETES COMMERCIAL MEDICAL POLICIES TO APPLY TO OUTPATIENT FACILITY SERVICES EFFECTIVE JAN. 13, 2014

References

Scrivani SJ, Keith DA, Kaban LB. Temporomandibular disorders. N Engl J Med. 2008,359:2693-2705.

View Previous Versions

[Version 002 of V-23]
[Version 001 of V-23]

Table Attachment

Text Attachment

Procedure Code Attachments

Diagnosis Codes

ICD-9 Diagnosis Codes

Covered Diagnosis Codes for 29800, 29804, 64400, 70332, 70336, 70486-70488, 95831, 95851 and E1700-E1702:

524.60-524.69   

Covered Diagnosis Codes for 21073, 21480-21490

830.0830.1  

Non-covered Diagnosis Codes for 21073, 21480-21490, 70250, 70260, 76536, 78300, 78305, 95867, 95868, 95925, 95937 and 97033:

524.60-524.69   

ICD-10 Diagnosis Codes

INFORMATIONAL ONLY

Covered Diagnosis Codes

For 29800, 29804, 64400, 70332, 70336, 70486-70488, 95831, 95851 and E1700-E1702

M26.60M26.61M26.62M26.63
M26.69   

Covered Diagnosis Codes for 21073, 21480-21490

S01409AS03.0XXA  

Non-covered Diagnosis Codes for 21073, 21480-21490, 70250, 70260, 76536, 78300, 78305, 95867, 95868, 95925, 95937 and 97033

M26.60M26.61M26.62M26.63
M26.69   

Glossary





This policy is intended to document those medical guidelines used by Highmark Blue Cross Blue Shield Delaware for the purpose of coverage and reimbursement determinations under Highmark Blue Cross Blue Shield Delaware health benefit plans. These guidelines are appropriate for the majority of individuals with a particular disease, illness, or condition; however, each person's unique clinical circumstances may warrant individual consideration, based on review of applicable medical records.

Medical policies are designed to supplement the terms of a member's contract. The member's contract defines the benefits available; therefore, medical policies should not be construed as overriding specific contract language. In the event of conflict, the contract shall govern.

Medical policies do not constitute medical advice, nor the practice of medicine. Application of a medical policy to determine coverage in an individual instance is not intended and shall not be construed to supercede the professional judgment of a treating provider. In all situations, the treating provider must use his/her professional judgment to provide care he/she believes to be in the best interest of the patient, and the provider and patient remain responsible for all treatment decisions.

Highmark Blue Cross Blue Shield Delaware retains the right to review and update its medical policy guidelines at its sole discretion. These guidelines are the proprietary information of Highmark Blue Cross Blue Shield Delaware. Any sale, copying or dissemination of the medical policies is prohibited; however, limited copying of medical policies is permitted for individual use.



back to top